← Third Avenue Management, latest 13F
Supernus Pharmaceuticals
In Third Avenue Management's portfolio · Third Avenue Management
Ticker SUPN
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Third Avenue Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | Add 3% | 157,150 | 1.1% |
| Q2 2026 | No change | 152,724 | 1.1% |
| Q1 2026 | Reduce 19% | 152,724 | 1.3% |
| Q4 2025 | No change | 189,493 | 1.7% |
| Q3 2025 | No change | 189,493 | 1.7% |
| Q2 2025 | No change | 189,493 | 1.2% |
| Q1 2025 | No change | 189,493 | 1.2% |
| Q4 2024 | No change | 189,493 | 1.3% |
| Q3 2024 | No change | 189,493 | 1.0% |
| Q2 2024 | Add 18% | 189,118 | 0.9% |
| Q1 2024 | No change | 159,717 | 0.9% |
| Q4 2023 | Add 37% | 159,717 | 0.8% |
| Q3 2023 | Add 74% | 116,549 | 0.5% |
| Q2 2023 | Add 2626% | 67,062 | 0.3% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.